Skip to main content

10 Result(s)

within J. Kattan Remove this filter Medicine & Public Health Remove this filter

and

  1. Article

    Open Access

    Correction: Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service

    N. Radhakrishnan, M. Liu, B. Idowu, A. Bansari, K. Rathi… in BMC Infectious Diseases (2023)

    Download PDF (657 KB) View Article

  2. Article

    Open Access

    Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service

    While existing evidence suggests less severe clinical manifestations and lower mortality are associated with the Omicron variant as compared to the Delta variant. However, these studies fail to control for dif...

    N. Radhakrishnan, M. Liu, B. Idowu, A. Bansari, K. Rathi… in BMC Infectious Diseases (2023)

    Download PDF (1259 KB) View Article

  3. No Access

    Article

    Comparative genomic characterization of melanoma of known and unknown primary

    This study aims to genomically characterize melanoma of unknown primary (MUP) in comparison to melanomas of cutaneous primary (MCP).

    E. Rassy, S. Boussios, A. Chebly, C. Farra… in Clinical and Translational Oncology (2021)

  4. No Access

    Article

    Overview on the role of preoperative therapy in the management of kidney cancer

    The advent of molecular therapy through targeted kinase inhibitors (TKI) has revolutionized the management of renal cell carcinoma. Although surgical resection remains the cornerstone of any therapeutic plan, ...

    T. Assi, E. El Rassy, F. Farhat, J. Kattan in Clinical and Translational Oncology (2020)

  5. No Access

    Article

    Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder

    Metastatic urothelial carcinoma of the bladder is a rarely curable disease. Patients receive systemic therapy with limited response rates and survival benefits. The rescue regimens of these patients who have f...

    E. El Rassy, T. Assi, Z. Bakouny, N. Pavlidis… in Clinical and Translational Oncology (2019)

  6. Article

    Comment on ‘Failure of intravitreal bevacizumab in the treatment of choroidal metastasis’

    H R Kourie, J Antoun, J Kattan in Eye (2015)

    Download PDF (117 KB) View Article

  7. No Access

    Article

    A risk prediction model for severe intraventricular hemorrhage in very low birth weight infants and the effect of prophylactic indomethacin

    Develop a risk prediction model for severe intraventricular hemorrhage (IVH) in very low birth weight infants (VLBWI).

    M J Luque, J L Tapia, L Villarroel, G Marshall, G Musante… in Journal of Perinatology (2014)

  8. No Access

    Article

    Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer

    This prospective phase II trial aims to evaluate the sequential FOLFOX-6 and gemcitabine followed by adapted maintenance for advanced pancreatic cancer. Treatment included FOLFOX-6 for 4 cycles, followed seque...

    M. Ghosn, A. Saroufim, J. Kattan, G. Chahine, F. Nasr, F. Farhat in Medical Oncology (2012)

  9. No Access

    Article

    Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension

    To evaluate whether early treatment with inhaled nitric oxide (iNO) will prevent newborns with moderate respiratory failure from develo** severe hypoxemic respiratory failure (oxygenation index (OI)⩾40).

    A González, J Fabres, I D'Apremont, G Urcelay, M Avaca… in Journal of Perinatology (2010)

  10. No Access

    Article

    Phase II trial of pirarubicin in the treatment of advanced bladder cancer

    Doxorubicin is one of the standard drugs in the chemotherapy of advanced urothelial tumors. Pirarubicin, a new anthracycline, turned out to be equally active and less toxic than its parent compound in preclini...

    M. Mahjoubi, J. Kattan, M. Ghosn, J. -P. Droz, I. Philippot… in Investigational New Drugs (1992)